These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8906825)

  • 1. A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.
    Schlueter CJ; Manning TC; Schodin BA; Kranz DM
    J Immunol; 1996 Nov; 157(10):4478-85. PubMed ID: 8906825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and binding properties of a single-chain T cell receptor.
    Schlueter CJ; Schodin BA; Tetin SY; Kranz DM
    J Mol Biol; 1996 Mar; 256(5):859-69. PubMed ID: 8601837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule.
    Tallquist MD; Weaver AJ; Pease LR
    J Immunol; 1998 Jan; 160(2):802-9. PubMed ID: 9551915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
    Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
    Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent cytolytic response by a CD8+ CTL clone to multiple peptides from the same protein in association with an allogeneic class I MHC molecule.
    Kageyama S; Tsomides TJ; Fukusen N; Papayannopoulos IA; Eisen HN; Sykulev Y
    J Immunol; 2001 Mar; 166(5):3028-34. PubMed ID: 11207252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interface-disrupting amino acids establish specificity between T cell receptors and complexes of major histocompatibility complex and peptide.
    Huseby ES; Crawford F; White J; Marrack P; Kappler JW
    Nat Immunol; 2006 Nov; 7(11):1191-9. PubMed ID: 17041605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
    J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.
    Jones LL; Colf LA; Bankovich AJ; Stone JD; Gao YG; Chan CM; Huang RH; Garcia KC; Kranz DM
    Biochemistry; 2008 Nov; 47(47):12398-408. PubMed ID: 18973345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.